======= CDC34 ======= == Gene Information == * **Official Symbol**: CDC34 * **Official Name**: cell division cycle 34 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=997|997]] * **UniProt**: [[https://www.uniprot.org/uniprot/P49427|P49427]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CDC34&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CDC34|Open PubMed]] * **OMIM**: [[https://omim.org/entry/116948|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In vitro catalyzes 'Lys- 48'-linked polyubiquitination (PubMed:22496338). Cooperates with the E2 UBCH5C and the SCF(FBXW11) E3 ligase complex for the polyubiquitination of NFKBIA leading to its subsequent proteasomal degradation. Performs ubiquitin chain elongation building ubiquitin chains from the UBE2D3-primed NFKBIA-linked ubiquitin. UBE2D3 acts as an initiator E2, priming the phosphorylated NFKBIA target at positions 'Lys-21' and/or 'Lys-22' with a monoubiquitin. Cooperates with the SCF(SKP2) E3 ligase complex to regulate cell proliferation through ubiquitination and degradation of MYBL2 and KIP1. Involved in ubiquitin conjugation and degradation of CREM isoform ICERIIgamma and ATF15 resulting in abrogation of ICERIIgamma- and ATF5-mediated repression of cAMP-induced transcription during both meiotic and mitotic cell cycles. Involved in the regulation of the cell cycle G2/M phase through its targeting of the WEE1 kinase for ubiquitination and degradation. Also involved in the degradation of beta-catenin. Is target of human herpes virus 1 protein ICP0, leading to ICP0- dependent dynamic interaction with proteasomes (PubMed:10329681, PubMed:10373550, PubMed:10871850, PubMed:11675391, PubMed:12037680, PubMed:15652359, PubMed:17461777, PubMed:17698585, PubMed:19112177, PubMed:19126550, PubMed:19945379, PubMed:20061386, PubMed:20347421). {ECO:0000269|PubMed:10329681, ECO:0000269|PubMed:10373550, ECO:0000269|PubMed:10871850, ECO:0000269|PubMed:11675391, ECO:0000269|PubMed:12037680, ECO:0000269|PubMed:15652359, ECO:0000269|PubMed:17461777, ECO:0000269|PubMed:17698585, ECO:0000269|PubMed:19112177, ECO:0000269|PubMed:19126550, ECO:0000269|PubMed:19945379, ECO:0000269|PubMed:20061386, ECO:0000269|PubMed:20347421, ECO:0000269|PubMed:22496338}. |UQ con| |positive regulation of inclusion body assembly| |regulation of inclusion body assembly| |cellular response to interferon-beta| |negative regulation of cAMP-mediated signaling| |response to interferon-beta| |DNA replication initiation| |ubiquitin conjugating enzyme activity| |regulation of cAMP-mediated signaling| |protein K48-linked ubiquitination| |positive regulation of neuron apoptotic process| |positive regulation of neuron death| |G1/S transition of mitotic cell cycle| |DNA-dependent DNA replication| |cell cycle G1/S phase transition| |regulation of neuron apoptotic process| |DNA replication| |ubiquitin-protein transferase activity| |mitotic cell cycle phase transition| |cell cycle phase transition| |protein polyubiquitination| |regulation of neuron death| |proteasome-mediated ubiquitin-dependent protein catabolic process| |proteasomal protein catabolic process| |nuclear speck| |negative regulation of intracellular signal transduction| |positive regulation of cellular component biogenesis| |ubiquitin-dependent protein catabolic process| |response to growth factor| |modification-dependent protein catabolic process| |modification-dependent macromolecule catabolic process| |proteolysis involved in cellular protein catabolic process| |mitotic cell cycle process| |cellular protein catabolic process| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |protein catabolic process| |mitotic cell cycle| |protein ubiquitination| |positive regulation of cell death| |DNA metabolic process| |protein modification by small protein conjugation| |cellular macromolecule catabolic process| |regulation of cellular component biogenesis| |protein modification by small protein conjugation or removal| |cell cycle process| |cellular response to cytokine stimulus| |macromolecule catabolic process| |organonitrogen compound catabolic process| |response to cytokine| |positive regulation of cellular component organization| |negative regulation of signal transduction| |proteolysis| |cell cycle| |negative regulation of cell communication| |negative regulation of signaling| |ATP binding| |regulation of apoptotic process| |regulation of programmed cell death| |negative regulation of response to stimulus| |regulation of cell death| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |organic substance catabolic process| |cellular catabolic process| |regulation of intracellular signal transduction| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp260|ABT-702 0.1μM R06 exp260]]|-1.77| |[[:results:exp533|TNF-alpha 44ng/ml R08 exp533]]|2.5| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3963 * **Expression level (log2 read counts)**: 4.76 {{:chemogenomics:nalm6 dist.png?nolink |}}